Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women

Open access
Franconi, Flavia, Campesi, Ilaria · 2014 · British Journal of Pharmacology

Abstract

Pharmacological response depends on multiple factors and one of them is sex–gender. Data on the specific effects of sex–gender on pharmacokinetics, as well as the safety and efficacy of numerous medications, are beginning to emerge. Nevertheless, the recruitment of women for clinical research is inadequate, especially during the first phases. In general, pharmacokinetic differences between males and females are more numerous and consistent than disparities in pharmacodynamics. However, sex–gender pharmacodynamic differences are now increasingly being identified at the molecular level. It is now even becoming apparent that sex–gender influences pharmacogenomics and pharmacogenetics. Sex‐related differences have been reported for several parameters, and it is consistently shown that women have a worse safety profile, with drug adverse reactions being more frequent and severe in women than in men. Overall, the pharmacological status of women is less well studied than that of men and deserves much more attention. The design of clinical and preclinical studies should have a sex–gender‐based approach with the aim of tailoring therapies to an individual's needs and concerns. Linked Articles: This article is part of a themed section on Biological Sex and Cardiovascular Pharmacology. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue‐3

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12362

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 187

  1. 10.1016/j.phrs.2004.11.006 · doi:10.1016/j.phrs.2004.11.006
  2. 10.1111/bph.12444 · DOI · Paper page
  3. 10.1016/j.cbi.2010.04.002 · DOI
  4. 10.2165/00003088-200544100-00001 · DOI · Paper page
  5. 10.2217/17455057.1.2.183 · DOI
  6. 10.1038/sj.clpt.6100377 · DOI
  7. 10.3109/10623320109165322 · DOI
  8. 10.1007/s11095-008-9635-y · DOI
  9. 10.1097/PSY.0b013e31818105ed · DOI
  10. 10.1097/PSY.0b013e3182080d73 · DOI
  11. 10.1186/2191-219X-2-57 · DOI
  12. 10.2174/138920009788498996 · DOI
  13. 10.1016/S0001-4079(19)33352-7 · doi:10.1016/s0001-4079(19)33352-7
  14. 10.1371/journal.pone.0054289 · DOI · Paper page
  15. 10.1586/ecp.12.58 · DOI
  16. 10.1196/annals.1422.019 · DOI · Paper page
  17. 10.1378/chest.121.3.906 · DOI
  18. 10.1097/00062752-200009000-00005 · DOI
  19. 10.1182/blood-2006-03-013151 · DOI
  20. 10.1124/dmd.106.012070 · DOI · Paper page
  21. 10.1124/jpet.301.1.145 · DOI · Paper page
  22. 10.1016/j.pharmthera.2012.07.010 · DOI · Paper page
  23. 10.1016/S0735-1097(02)02379-3 · DOI · Paper page
  24. Campesi I, 2013, Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex‐gender specific manner in healthy young humans, Am J Transl Res, 5, 497
  25. 10.1161/hc4201.097834 · DOI · Paper page
  26. 10.1161/HYPERTENSIONAHA.111.182337 · DOI
  27. 10.1038/clpt.2009.89 · DOI
  28. 10.4158/EP.14.2.162 · DOI
  29. 10.1016/S0008-6363(01)00528-4 · DOI
  30. 10.1002/bdd.512 · DOI
  31. 10.1161/01.CIR.0000032002.22105.7A · DOI · Paper page
  32. 10.1007/BF03261926 · DOI
  33. 10.2165/00002018-200124080-00002 · DOI · Paper page
  34. 10.1016/S0008-6363(01)00527-2 · DOI · Paper page
  35. 10.1161/01.HYP.0000124253.98863.86 · doi:10.1161/01.hyp.0000124253.98863.86
  36. 10.4061/2010/164906 · DOI
  37. 10.1007/s00439-007-0430-3 · DOI · Paper page
  38. 10.1016/j.amjcard.2009.06.003 · doi:10.1016/j.amjcard.2009.06.003
  39. 10.1007/s10157-005-0368-5 · DOI · Paper page
  40. 10.1016/S1550-8579(08)80008-3 · DOI
  41. European Medicines Agency, 2010, Guideline on the Investigation of Bioequivalence
  42. 10.1345/aph.1L036 · DOI
  43. 10.1055/s-0038-1656045 · DOI
  44. FDA(2010).Evaluation of Gender Differences in Clinical Investigations – Information Sheet Guidance for Institutional Review Boards and Clinical Investigators: U. S. Department of Health and Human Services.
  45. 10.1016/j.jelectrocard.2003.09.054 · DOI
  46. 10.1016/j.phrs.2006.11.001 · DOI · Paper page
  47. 10.1016/j.phrs.2007.11.007 · DOI
  48. 10.2174/138161211795656918 · doi:10.2174/138161211795656918
  49. 10.4155/tde.11.117 · DOI
  50. 10.1007/978-3-642-30726-3_6 · DOI
  51. 10.1016/j.ijpharm.2011.04.069 · DOI · Paper page
  52. 10.1161/JAHA.112.002584 · DOI
  53. 10.1378/chest.11-0404 · doi:10.1378/chest.11-0404
  54. 10.1016/j.yjmcc.2010.06.005 · DOI · Paper page
  55. 10.1124/dmd.110.035345 · DOI
  56. 10.1146/annurev.pharmtox.44.101802.121453 · DOI · Paper page
  57. 10.1161/01.CIR.102.20.2473 · DOI · Paper page
  58. 10.1124/jpet.105.094979 · DOI
  59. 10.1111/j.1365-2125.1995.tb04554.x · DOI
  60. 10.2217/pgs.09.102 · DOI
  61. 10.1097/00004872-200210000-00030 · doi:10.1097/00004872-200210000-00030
  62. 10.1002/syn.20541 · DOI
  63. 10.1159/000216582 · DOI
  64. 10.2165/11318100-000000000-00000 · DOI · Paper page
  65. 10.1113/jphysiol.2010.199935 · DOI
  66. 10.3109/03602532.2011.567391 · DOI · Paper page
  67. 10.1016/j.jprot.2011.01.015 · DOI
  68. Institute of Medicine, 2010, Women's Health Research: Progress, Pitfalls, and Promise
  69. 10.1161/CIRCULATIONAHA.107.706820 · DOI · Paper page
  70. 10.1016/j.pbiomolbio.2005.05.010 · DOI · Paper page
  71. 10.1111/j.1469-7793.2001.0161m.x · DOI · Paper page
  72. 10.1177/0091270009359525 · DOI
  73. 10.1093/eurheartj/ehi397 · DOI · Paper page
  74. 10.1345/aph.1M147 · DOI
  75. 10.1038/253355a0 · DOI · Paper page
  76. Jones SG, 2009, Distal upper and lower limb fractures associated with thiazolidinedione use, Am J Manag Care, 15, 491
  77. 10.3109/08037051003768247 · DOI
  78. 10.1080/07853890600989211 · DOI · Paper page
  79. 10.1111/j.1752-8062.2009.00094.x · DOI
  80. 10.2165/00003495-199550010-00001 · DOI
  81. 10.1111/j.1365-2710.2010.01242.x · DOI
  82. 10.1111/j.1476-5381.2012.01922.x · DOI
  83. 10.1097/00004872-200018050-00017 · DOI
  84. 10.1002/j.1552-4604.1995.tb04039.x · doi:10.1002/j.1552-4604.1995.tb04039.x
  85. 10.1016/S0002-9149(97)89205-3 · DOI
  86. 10.1016/S0735-1097(00)00849-4 · DOI · Paper page
  87. 10.1016/j.taap.2012.04.001 · DOI
  88. 10.1016/j.jacc.2012.03.081 · doi:10.1016/j.jacc.2012.03.081
  89. 10.1016/j.jacc.2011.09.067 · DOI · Paper page
  90. 10.1111/j.1469-8986.1981.tb01840.x · DOI
  91. 10.1067/mcp.2000.109356 · DOI
  92. 10.1081/NCN-200027624 · doi:10.1081/ncn-200027624
  93. 10.1016/j.cca.2009.04.010 · DOI
  94. 10.1016/j.amjmed.2012.02.025 · DOI
  95. 10.1248/bpb.b212021 · DOI
  96. Kurrelmeyer K, 2003, Platelet hyperreactivity in women from families with premature atherosclerosis, J Am Med Womens Assoc, 58, 272
  97. 10.18553/jmcp.2008.14.3.271 · DOI
  98. Legato MJ, 2009, Principles of Gender‐Specific Medicine
  99. 10.1172/JCI200319429 · DOI
  100. 10.1124/jpet.301.2.551 · DOI
  101. 10.1152/ajpheart.00985.2009 · DOI
  102. 10.1124/dmd.107.014845 · DOI
  103. 10.1053/cp.1999.v66.103400001 · doi:10.1053/cp.1999.v66.103400001 · Paper page
  104. 10.1177/1753944712468499 · DOI
  105. 10.1046/j.1365-2125.1999.00855.x · DOI
  106. 10.1007/978-3-642-30726-3_2 · DOI
  107. 10.1124/dmd.31.5.637 · doi:10.1124/dmd.31.5.637
  108. 10.1017/S1092852913000667 · DOI · Paper page
  109. 10.1016/j.mam.2011.02.001 · DOI
  110. 10.1097/FPC.0b013e328348c6db · DOI
  111. 10.1096/fj.08-114348 · DOI
  112. 10.1126/science.1112062 · DOI · Paper page
  113. 10.1055/s-0031-1299774 · DOI
  114. 10.1016/j.genm.2008.03.009 · DOI
  115. 10.1186/2042-6410-2-14 · DOI
  116. 10.1016/S0009-9236(96)90172-1 · DOI
  117. 10.1136/hrt.2010.199760 · DOI
  118. 10.1113/jphysiol.2010.192492 · DOI
  119. 10.1124/pr.55.2.1 · DOI
  120. 10.1016/j.jacc.2011.11.008 · DOI
  121. 10.3109/03602539808996322 · DOI · Paper page
  122. 10.1016/0735-1097(94)90772-2 · DOI · Paper page
  123. 10.1016/j.pharmthera.2011.11.002 · DOI
  124. 10.1111/j.1540-8159.2006.00407.x · DOI · Paper page
  125. 10.1016/j.yjmcc.2009.07.016 · DOI
  126. 10.1016/j.amjcard.2012.12.037 · DOI · Paper page
  127. 10.1159/000327782 · DOI
  128. 10.1160/TH11-03-0178 · DOI
  129. 10.1111/j.1525-1373.2000.22359.x · doi:10.1111/j.1525-1373.2000.22359.x · Paper page
  130. Nicholas JS, 1932, The use of sodium amytal in the production of anesthesia in the rat, J Pharmacol Exp Ther, 46, 125
  131. 10.1016/j.taap.2004.01.010 · DOI · Paper page
  132. 10.1186/1472-6904-7-9 · DOI · Paper page
  133. 10.1016/j.ahj.2008.07.028 · DOI · Paper page
  134. 10.1016/j.whi.2008.09.009 · DOI
  135. 10.1136/bmj.329.7456.15 · DOI · Paper page
  136. 10.1200/JCO.1996.14.1.78 · DOI · Paper page
  137. 10.1161/01.ATV.0000186185.13977.94 · DOI
  138. 10.1016/0006-2952(58)90024-8 · DOI
  139. 10.1007/978-3-642-30726-3_7 · DOI
  140. 10.1007/978-3-642-30726-3 · DOI
  141. 10.1007/978-3-642-30726-3_1 · DOI
  142. 10.1152/ajpregu.00145.2007 · DOI
  143. 10.1097/HCO.0b013e328333f95f · DOI
  144. 10.1016/S1043-2760(01)00432-5 · DOI · Paper page
  145. Ross S, 1985, Placebo: Theory, Research and Mechanisms, 67
  146. 10.1111/j.1365-2362.2005.01556.x · DOI
  147. 10.2215/CJN.04140907 · DOI
  148. Saenz‐Campos D, 1995, Gender related pharmacokinetics of diltiazem in healthy subjects, Int J Clin Pharmacol Ther, 33, 397
  149. 10.1007/s002130000574 · DOI
  150. 10.1038/jhh.2010.74 · DOI
  151. Schuetz EG, 1995, Interindividual variation in expression of P‐glycoprotein in normal human liver and secondary hepatic neoplasms, J Pharmacol Exp Ther, 275, 1011, 10.1016/S0022-3565(25)12089-2 · DOI · Paper page
  152. 10.1046/j.1523-1755.2002.00624.x · DOI
  153. 10.1038/sj.clpt.6100226 · DOI · Paper page
  154. 10.1007/978-3-642-30726-3_11 · DOI
  155. 10.1016/S0002-9343(00)00529-5 · DOI
  156. 10.2165/00003088-198815020-00002 · DOI
  157. 10.1345/aph.1M416 · DOI
  158. 10.1001/jama.1988.03410070095035 · DOI · Paper page
  159. 10.1155/2011/187103 · DOI · Paper page
  160. 10.1007/978-3-642-30726-3_5 · DOI
  161. 10.1016/j.socscimed.2011.05.033 · DOI · Paper page
  162. 10.2459/JCM.0b013e328324991c · DOI
  163. 10.1093/eurheartj/ehi819 · DOI · Paper page
  164. 10.1016/j.acvd.2009.02.005 · DOI
  165. 10.1093/eurheartj/ehn427 · DOI · Paper page
  166. 10.1586/erc.09.155 · DOI
  167. 10.1177/1741826710389369 · DOI
  168. 10.1182/blood-2012-01-405498 · DOI
  169. 10.1161/01.HYP.0000124251.06056.8e · DOI
  170. 10.1093/eurpub/ckq155 · DOI
  171. 10.1016/j.jacc.2011.09.075 · DOI
  172. 10.1124/mol.109.056705 · DOI · Paper page
  173. 10.1016/j.curobgyn.2005.03.005 · doi:10.1016/j.curobgyn.2005.03.005
  174. 10.1056/NEJM199604253341703 · DOI · Paper page
  175. 10.1111/j.1365-2125.1994.tb04308.x · DOI
  176. Wolbrette D, 2002, Gender differences in the proarrhythmic potential of QT‐prolonging drugs, Curr Womens Health Rep, 2, 105
  177. 10.1016/S0378-4274(01)00263-6 · doi:10.1016/s0378-4274(01)00263-6
  178. 10.1016/S0304-3835(02)00435-4 · DOI
  179. 10.1182/blood-2005-03-1290 · DOI · Paper page
  180. 10.1007/BF03188796 · DOI
  181. 10.1016/j.cnur.2009.06.002 · DOI
  182. 10.4161/epi.6.5.15335 · DOI · Paper page
  183. 10.1371/journal.pone.0023506 · DOI · Paper page
  184. 10.1002/jat.1698 · DOI
  185. 10.1124/dmd.109.028209 · DOI
  186. 10.1080/09603123.2011.634389 · doi:10.1080/09603123.2011.634389
  187. 10.1055/s-0037-1613827 · doi:10.1055/s-0037-1613827

Cited by

See all 251

Metadata

Authors
Franconi, F., & Campesi, I.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2014-01-13
Volume
171
Issue
3
Pages
580-594
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2121841953
Cited by
251
References
22
FWCI
10.40
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.